Spero Therapeutics Stock Price History
| SPRO Stock | USD 2.37 0.11 4.44% |
Below is the normalized historical share price chart for Spero Therapeutics extending back to November 02, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Spero Therapeutics stands at 2.37, as last reported on the 21st of July, with the highest price reaching 2.53 and the lowest price hitting 2.35 during the day.
If you're considering investing in Spero Stock, it is important to understand the factors that can impact its price. Spero Therapeutics is out of control given 3 months investment horizon. Spero Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.13, which indicates the firm had a 0.13 % return per unit of risk over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 3.96% are justified by taking the suggested risk. Use Spero Therapeutics Semi Deviation of 2.15, coefficient of variation of 807.14, and Risk Adjusted Performance of 0.1254 to evaluate company specific risk that cannot be diversified away. At this time, Spero Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 21st of July 2025, Liabilities And Stockholders Equity is likely to grow to about 120.1 M, while Common Stock Shares Outstanding is likely to drop about 27.3 M. . As of the 21st of July 2025, Price Earnings To Growth Ratio is likely to grow to 0, while Price To Sales Ratio is likely to drop 1.93. Spero Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of November 2017 | 200 Day MA 1.2648 | 50 Day MA 2.1643 | Beta 1.308 |
Sharpe Ratio = 0.1256
| Best Portfolio | Best Equity | SPRO | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 31.52 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.96 actual daily | 79 79% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Spero Therapeutics is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spero Therapeutics by adding it to a well-diversified portfolio.
Price Book 3.9187 | Enterprise Value Ebitda 0.7464 | Price Sales 2.9721 | Shares Float 41.7 M | Wall Street Target Price 5 |
Spero Therapeutics Stock Price History Chart
There are several ways to analyze Spero Stock price data. The simplest method is using a basic Spero candlestick price chart, which shows Spero Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 9, 2025 | 3.04 |
| Lowest Price | May 8, 2025 | 0.57 |
Spero Therapeutics July 21, 2025 Stock Price Synopsis
Various analyses of Spero Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Spero Stock. It can be used to describe the percentage change in the price of Spero Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Spero Stock.| Spero Therapeutics Price Rate Of Daily Change | 0.96 | |
| Spero Therapeutics Price Daily Balance Of Power | (0.61) | |
| Spero Therapeutics Price Action Indicator | (0.12) |
Spero Therapeutics July 21, 2025 Stock Price Analysis
Spero Stock Price History Data
The price series of Spero Therapeutics for the period between Tue, Apr 22, 2025 and Mon, Jul 21, 2025 has a statistical range of 2.47 with a coefficient of variation of 58.29. The price distribution for the period has arithmetic mean of 1.81. The median price for the last 90 days is 2.47. The company had dividends distributed to its stock-holders on 17th of September 2013.| Open | High | Low | Close | Volume | ||
07/21/2025 | 2.48 | 2.53 | 2.35 | 2.37 | ||
07/18/2025 | 2.48 | 2.53 | 2.35 | 2.37 | 970,578 | |
07/17/2025 | 2.49 | 2.51 | 2.47 | 2.48 | 500,806 | |
07/16/2025 | 2.49 | 2.52 | 2.45 | 2.47 | 867,098 | |
07/15/2025 | 2.61 | 2.63 | 2.47 | 2.49 | 1,018,637 | |
| 07/14/2025 | 2.79 | 2.84 | 2.61 | 2.64 | 909,788 | |
07/11/2025 | 2.85 | 2.90 | 2.76 | 2.81 | 1,005,881 | |
07/10/2025 | 3.00 | 3.07 | 2.83 | 2.84 | 1,842,590 | |
07/09/2025 | 2.97 | 3.22 | 2.95 | 3.04 | 1,724,993 | |
07/08/2025 | 2.89 | 3.00 | 2.89 | 2.94 | 629,955 | |
07/07/2025 | 2.90 | 2.94 | 2.90 | 2.90 | 844,657 | |
07/03/2025 | 2.90 | 2.94 | 2.90 | 2.91 | 390,072 | |
| 07/02/2025 | 2.90 | 3.03 | 2.90 | 2.90 | 1,098,186 | |
07/01/2025 | 2.92 | 2.95 | 2.90 | 2.90 | 639,760 | |
06/30/2025 | 2.99 | 3.00 | 2.90 | 2.90 | 1,155,574 | |
06/27/2025 | 2.91 | 3.09 | 2.90 | 2.94 | 1,689,768 | |
06/26/2025 | 2.94 | 2.94 | 2.87 | 2.90 | 557,954 | |
06/25/2025 | 2.90 | 2.93 | 2.79 | 2.90 | 1,466,871 | |
06/24/2025 | 2.97 | 2.97 | 2.81 | 2.88 | 1,012,567 | |
06/23/2025 | 3.00 | 3.00 | 2.88 | 2.93 | 866,367 | |
06/20/2025 | 2.93 | 3.02 | 2.87 | 3.02 | 2,110,151 | |
06/18/2025 | 2.95 | 2.98 | 2.86 | 2.94 | 1,848,456 | |
06/17/2025 | 2.85 | 2.95 | 2.81 | 2.90 | 2,094,528 | |
06/16/2025 | 2.84 | 2.95 | 2.83 | 2.85 | 1,108,284 | |
06/13/2025 | 2.82 | 2.86 | 2.77 | 2.83 | 2,078,613 | |
06/12/2025 | 2.80 | 3.06 | 2.71 | 2.89 | 2,123,249 | |
| 06/11/2025 | 2.85 | 2.89 | 2.64 | 2.80 | 1,885,794 | |
06/10/2025 | 2.76 | 2.93 | 2.72 | 2.85 | 2,219,088 | |
06/09/2025 | 2.55 | 2.81 | 2.50 | 2.76 | 3,991,362 | |
06/06/2025 | 2.54 | 2.74 | 2.45 | 2.50 | 2,552,070 | |
06/05/2025 | 2.64 | 2.69 | 2.52 | 2.56 | 1,717,298 | |
06/04/2025 | 2.61 | 2.90 | 2.47 | 2.66 | 2,648,436 | |
06/03/2025 | 2.74 | 2.78 | 2.55 | 2.64 | 2,098,983 | |
06/02/2025 | 2.51 | 2.95 | 2.42 | 2.74 | 6,574,988 | |
| 05/30/2025 | 2.50 | 2.80 | 2.35 | 2.50 | 24,329,228 | |
05/29/2025 | 2.23 | 2.34 | 2.10 | 2.13 | 7,435,375 | |
| 05/28/2025 | 2.06 | 2.48 | 1.85 | 2.35 | 183,084,411 | |
05/27/2025 | 0.69 | 0.70 | 0.66 | 0.68 | 68,596 | |
05/23/2025 | 0.68 | 0.70 | 0.67 | 0.70 | 40,445 | |
05/22/2025 | 0.67 | 0.71 | 0.66 | 0.70 | 30,245 | |
05/21/2025 | 0.68 | 0.71 | 0.68 | 0.69 | 86,477 | |
05/20/2025 | 0.69 | 0.70 | 0.67 | 0.68 | 65,394 | |
05/19/2025 | 0.65 | 0.70 | 0.65 | 0.69 | 99,298 | |
05/16/2025 | 0.67 | 0.68 | 0.63 | 0.65 | 89,381 | |
05/15/2025 | 0.67 | 0.69 | 0.63 | 0.65 | 119,549 | |
| 05/14/2025 | 0.70 | 0.70 | 0.65 | 0.65 | 65,574 | |
05/13/2025 | 0.65 | 0.70 | 0.61 | 0.69 | 290,908 | |
| 05/12/2025 | 0.60 | 0.64 | 0.60 | 0.61 | 144,933 | |
05/09/2025 | 0.58 | 0.64 | 0.57 | 0.62 | 81,463 | |
05/08/2025 | 0.58 | 0.61 | 0.57 | 0.57 | 183,470 | |
05/07/2025 | 0.59 | 0.60 | 0.58 | 0.58 | 57,129 | |
05/06/2025 | 0.62 | 0.64 | 0.59 | 0.59 | 94,557 | |
| 05/05/2025 | 0.65 | 0.67 | 0.61 | 0.61 | 107,193 | |
| 05/02/2025 | 0.65 | 0.67 | 0.64 | 0.65 | 85,215 | |
05/01/2025 | 0.67 | 0.68 | 0.66 | 0.66 | 27,448 | |
04/30/2025 | 0.67 | 0.69 | 0.64 | 0.66 | 79,293 | |
04/29/2025 | 0.70 | 0.72 | 0.67 | 0.67 | 52,340 | |
04/28/2025 | 0.73 | 0.74 | 0.71 | 0.71 | 46,508 | |
04/25/2025 | 0.73 | 0.75 | 0.73 | 0.73 | 71,847 | |
04/24/2025 | 0.74 | 0.74 | 0.72 | 0.73 | 28,949 | |
04/23/2025 | 0.71 | 0.76 | 0.63 | 0.73 | 246,771 |
About Spero Therapeutics Stock history
Spero Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Spero is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Spero Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Spero Therapeutics stock prices may prove useful in developing a viable investing in Spero Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 54 M | 27.3 M | |
| Net Loss | -41.8 M | -43.9 M |
Spero Therapeutics Quarterly Net Working Capital |
|
Spero Therapeutics Stock Technical Analysis
Spero Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Spero Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Spero Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Spero Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Spero to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1254 | |||
| Jensen Alpha | 4.23 | |||
| Total Risk Alpha | (0.50) | |||
| Sortino Ratio | 0.9331 | |||
| Treynor Ratio | (1.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spero Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Spero Stock, please use our How to Invest in Spero Therapeutics guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spero Therapeutics. If investors know Spero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.753 | Earnings Share (1.28) | Revenue Per Share | Quarterly Revenue Growth (0.37) | Return On Assets |
The market value of Spero Therapeutics is measured differently than its book value, which is the value of Spero that is recorded on the company's balance sheet. Investors also form their own opinion of Spero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Spero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spero Therapeutics' market value can be influenced by many factors that don't directly affect Spero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.